Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| SAVA | Cassava Sciences, Inc. | 3.03% | 61.94 | 0.0% | $779.50m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -2.07% | 28.86 | 14.1% | $169.82m | |
| CTLT | Catalent, Inc. | 0.28% | 141.41 | 2.0% | $168.28m | |
| PRGO | Perrigo Co. Plc | 0.55% | 43.01 | 6.9% | $140.02m | |
| ICLR | ICON plc | 0.56% | 283.04 | 2.8% | $122.12m | |
| HZNP | Horizon Therapeutics Plc | 0.80% | 110.37 | 5.5% | $106.97m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.63% | 135.35 | 2.1% | $104.94m | |
| INDP | Indaptus Therapeutics, Inc. | -6.86% | 8.82 | 0.0% | $101.49m | |
| ARGX | argenx SE | -3.15% | 308.00 | 0.0% | $64.03m | |
| BHC | Bausch Health Cos., Inc. | -2.07% | 28.86 | 0.0% | $60.89m | |
| ENDP | Endo International Plc | -3.85% | 3.25 | 8.5% | $56.03m | |
| UTHR | United Therapeutics Corp. | -2.68% | 195.10 | 14.0% | $46.59m | |
| AXSM | Axsome Therapeutics, Inc. | 1.34% | 33.40 | 1.8% | $38.98m | |
| IRWD | Ironwood Pharmaceuticals, Inc. | 3.54% | 13.45 | 9.5% | $24.56m | |
| SAGE | SAGE Therapeutics, Inc. | -1.69% | 45.42 | 7.6% | $21.56m |
Company Profile
SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.